| 36493747 | Causal analysis of plasma IL-8 on carotid intima media thickness, a measure of subclinical atherosclerosis. | | 2023 |
| 37924278 | Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. | | 2023 |
| 38060059 | Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme? | | 2023 |
| 37409534 | Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report. | | 2023 |
| 37021583 | Cross-Sectional Gene-Smoking Interaction Analysis in Relation to Subclinical Atherosclerosis-Results From the IMPROVE Study. | | 2023 |
| 36642658 | How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis. | | 2023 |
| 34809444 | Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome. | Circulation Research | 2022 |
| 35432461 | LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank. | Frontiers in Genetics | 2022 |
| 35292153 | How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)? | Atherosclerosis | 2022 |
| 34906454 | The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. | Genet Med | 2022 |
| 35330330 | Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care. | Journal of Personalized Medicine | 2022 |
| 34635577 | Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care. | Open Heart | 2021 |
| 33517400 | Genome-wide association study of circulating interleukin 6 levels identifies novel loci. | Hum Mol Genet | 2021 |
| 33508743 | Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries. | Atherosclerosis | 2021 |
| 34194581 | Lack of Association of Gene Polymorphisms with Coronary Artery Disease in Pakistani Subjects. | Disease Markers | 2021 |
| 33436761 | The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals. | Scientific Reports | 2021 |
| 34521694 | Case-finding and genetic testing for familial hypercholesterolaemia in primary care. | Heart | 2021 |
| 34666015 | Genetic testing for familial hypercholesterolemia-past, present, and future. | Journal of Lipid Research | 2021 |
| 32833799 | Management of familial hypercholesterolaemia in childhood. | Current Opinion in Pediatrics | 2020 |
| 31893970 | PCSK6 Is a Key Protease in the Control of Smooth Muscle Cell Function in Vascular Remodeling. | Circ Res | 2020 |
| 31893465 | The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes. | Clinical Genetics | 2020 |
| 31996015 | Triglyceride-containing lipoprotein sub-fractions and risk of coronary heart disease and stroke: A prospective analysis in 11,560 adults. | Eur J Prev Cardiol | 2020 |
| 32396387 | Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274. | Circ Genom Precis Med | 2020 |
| 31809987 | Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries. | Atherosclerosis | 2020 |
| 32443900 | Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolaemia: A Propensity Score Analysis. | Life | 2020 |
| 33187671 | Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records. | Atherosclerosis | 2020 |
| 32618729 | Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register. | Current Opinion in Lipidology | 2020 |
| 31536851 | Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care. | Atherosclerosis | 2019 |
| 31746944 | Familial hypercholesterolaemia workshop for leveraging point-of-care testing and personalised medicine in association with the Lipid and Atherosclerosis Society of Southern Africa. | | 2019 |
| 31696945 | Statins for children with familial hypercholesterolemia. | | 2019 |
| 28705542 | Effect of Coronary Artery Disease risk SNPs on serum cytokine levels and cytokine imbalance in Premature Coronary Artery Disease. | Cytokine | 2019 |
| 30458964 | Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register. | Atherosclerosis | 2019 |
| 30545617 | A priori-defined Mediterranean-like dietary pattern predicts cardiovascular events better in north Europe than in Mediterranean countries. | International Journal of Cardiology | 2019 |
| 30056760 | Estimation of the prevalence of cholesteryl ester storage disorder in a cohort of patients with clinical features of familial hypercholesterolaemia. | Annals of Clinical Biochemistry | 2019 |
| 31089183 | Genetic variation in CADM2 as a link between psychological traits and obesity. | Scientific Reports | 2019 |
| 31181417 | Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study. | Atherosclerosis | 2019 |
| 31011892 | Polygenic Hypercholesterolemia and Cardiovascular Disease Risk. | Current Cardiology Reports | 2019 |
| 31372435 | Data on the association between a simplified Mediterranean diet score and the incidence of combined, cardio and cerebro vascular events. | Data in Brief | 2019 |
| 29188294 | Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis. | JAMA Cardiol | 2018 |
| 30270085 | Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia. | Atherosclerosis | 2018 |
| 30510157 | GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes. | Nat Commun | 2018 |
| 30311388 | ClinVar database of global familial hypercholesterolemia-associated DNA variants. | Hum Mutat | 2018 |
| 29879685 | Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales. | Atherosclerosis | 2018 |
| 29872056 | Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies. | Sci Rep | 2018 |
| 29937236 | Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis. | Atherosclerosis | 2018 |
| 29673405 | GWAS implicated risk variants in different genes contribute additively to increase the risk of coronary artery disease (CAD) in the Pakistani subjects. | Lipids in Health and Disease | 2018 |
| 29353228 | Association of lifelong occupation and educational level with subclinical atherosclerosis in different European regions. Results from the IMPROVE study. | Atherosclerosis | 2018 |
| 29304826 | The SNP rs10911021 is associated with oxidative stress in coronary heart disease patients from Pakistan. | Lipids in Health and Disease | 2018 |
| 29751283 | Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register. | Atherosclerosis | 2018 |
| 29208363 | The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data. | Journal of Clinical Lipidology | 2018 |